Company intelligence / Profile preview

Mivell

Vigonza, Padua, Italy

Ownership: Private
Development stage: Other

Overview

Mivell is an Italian healthcare company specializing in the development and commercialization of high-quality nutraceuticals and dermocosmetics. The company focuses on addressing specific physiological needs through innovative formulations, particularly in the areas of chronic inflammation, oxidative stress, and women's health. Their product portfolio includes specialized supplements designed to support patients with conditions such as endometriosis and chronic pelvic pain. Mivell emphasizes scientific research and the use of standardized natural extracts to ensure the efficacy and safety of its therapeutic solutions.

Therapeutic areas: ImmunologyWomen's HealthMetabolic Disorders
Modalities: Small moleculeNatural extracts
Industry: Food & Nutrition

Beyond the preview

Go deeper on Mivell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mivell.

Explore the full profile